Bevacizumab is a humanized IgG1 monoclonal antibody which binds to and sterically interferes with the vascular endothelial growth factor-A (VEGF-A), preventing receptor activation.
Bevacizumab is a humanized IgG1 monoclonal antibody. This humanized IgG1 monoclonal antibody binds to. This sterically interferes with the vascular endothelial growth factor-A (VEGF). A is preventing receptor activation. VEGF is A.